ARCHIVES

FDA cancer therapeutics review split among three units in reorganization.

This article is from The Cancer Letter archive.

Vol. 29 No. 37 | October 10, 2003

Download PDF Visit The Full Archive

Related Articles

Lung Cancer Screening Trial Opens

September 20, 2002

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

Tom King To Leave NCI For Kennedy Ethics Institute; Cal Baldwin To Take NIH Job

June 27, 1980

U.S. Cancer Mortality Dropped Slightly In 2003, ACS Report Finds.

February 10, 2006

House Approves Additional Funds For NIH and FDA.

June 20, 2008

In Brief: Little Doubt That DeVita, Frederickson Will Keep Their Jobs; New DCT Projects May Not Be Funded

March 6, 1981